Business Context and Reporting Period
Company: Capstone Holding Corp. (CAPS)
Filing Type: Form 8-K (Current Report)
Date of Report: June 11, 2026
Event: Entry into a Material Definitive Agreement regarding an Equity Line Financing.
Key Financial Metrics and Agreement Terms
This filing details the restructuring of an existing equity line financing rather than reporting standard periodic financial results (e.g., revenue, net income). Key terms include:
- Total Facility Size: Up to $20,000,000 in aggregate gross purchase price.
- Purchase Price: 97% of the volume-weighted average price (VWAP) during the applicable valuation period.
- Issuance Cap: Each purchase is capped at the lesser of 1,000,000 shares or 25% of trading volume during the valuation period.
- Minimum Price Threshold: Default is 75% of the prior day's closing price (Pre-Market) or 75% of the last sale price (Intraday) if not otherwise designated.
- Placement Agent Fee: 7.0% of gross proceeds per closing, plus up to $15,000 in reimbursable expenses.
- Shares Previously Issued: 1,543,400 shares issued under the prior agreement as of May 27, 2026.
- Registered Shares: 4,975,197 shares were registered under Form S-1 (File No. 333-287745) effective June 11, 2025.
Material Changes Versus Prior Period
The Company entered into an Amended and Restated Common Stock Purchase Agreement on June 11, 2026, superseding the Original Agreement (and its amendments from June and July 2025). The primary material change is the modification of purchase mechanics:
- Previous Mechanism: Standard VWAP Purchase.
- New Mechanism: Two time-bracketed options:
- Pre-Market VWAP Purchase: Notice delivered 6:00 a.m. – 9:00 a.m. ET; valuation begins 9:30:01 a.m. ET.
- Intraday VWAP Purchase: Notice delivered 9:00:01 a.m. – 3:30 p.m. ET; valuation begins at the later of 9:30:01 a.m. ET or Investor acknowledgment.
- Valuation Termination: Valuation periods now explicitly terminate if the sale price falls below the minimum threshold or if trading volume exceeds the applicable threshold.
Guidance, Outlook, and Risks
Management Commentary: The filing does not contain forward-looking guidance, earnings outlook, or specific management commentary beyond the description of the agreement terms.
Risks and Contingencies:
- Dilution: Issuance of up to $20 million in new shares will dilute existing shareholders.
- Market Volatility: The ability to draw down funds is contingent on market volume and price thresholds; if the stock price falls below the minimum threshold, the valuation period terminates immediately.
- Unregistered Securities: Securities not covered by the effective Registration Statement are sold under Section 4(a)(2) and Rule 506(b) exemptions and cannot be resold in the U.S. without registration or an exemption.
Important Facts for Investor Verification
- Verify the current outstanding balance of the $20 million facility to determine remaining capacity.
- Review the specific "Exchange Cap" definition in the Original Agreement to understand if it limits the total issuance below the $20 million gross purchase price.
- Monitor the Company's trading volume to assess the practical limit of the 25% volume cap on daily purchases.
- Confirm the impact of the 7.0% placement agent fee on the net proceeds received by the Company.
- Check subsequent filings for actual drawdowns and share issuances under the new time-bracketed mechanics.